Culture Biosciences
Culture Biosciences is seeking a Senior Software Engineer to design and develop scalable applications for its cloud bioprocessing platform, Console. The role involves building testing infrastructure, creating hardware-in-the-loop emulators, and partnering with cross-functional teams to deliver reliable software solutions. This position requires a background in software development engineering in test or similar automation-focused roles to support safe iteration and production readiness.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2016
Culture Biosciences offers an integrated suite of bioprocess development products and services, including Console (cloud-based bioreactor management and data analytics software), Stratyx (mobile laboratory bioreactors), and Nexxys (expert-run bioprocessing services). Their platform enables biotech and biomanufacturing customers to design, monitor, and analyze cell culture experiments remotely, accelerating upstream process development and reducing time to market. By combining cloud-native software, flexible bioreactor hardware, and on-demand lab operations, Culture Biosciences helps customers remove bottlenecks and scale bioprocesses more reliably.
Firm Advises Culture Biosciences on Series C Financing Round
Dec 18, 2025
Cytiva Expands Collaboration with Culture Biosciences
Aug 6, 2025
Culture Biosciences unveils Stratyx™ 250, the first cloud-integrated, mobile bioreactor for cell culture process development
Apr 1, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Culture Biosciences.
24% above the average for this role
Culture Biosciences Raises $80M Series B to Tackle Demand for Large-Scale Biomanufacturing
Oct 14, 2021